Rakesh Jhunjhunwala's portfolio stock has all buy ratings, but target below issue price
indiatimes.com
economics
2022-06-06 06:45:00

AgenciesThe brokerage believes that the company is backed by strong growth in retail health, healthy earnings growth led by normalization in the claim ratio and limited cyclicality risk.New Delhi: One of the latest debutants from Rakesh Jhunjhunwala's portfolio, Star Health and Allied Insurance Company, is not in the pink of its health. The scrip settled 2 per cent lower at Rs 701.15 on BSE on Friday. It is down about 22 per cent from its issue price of Rs 900, whereas if compared to its highest price of Rs 940, the counter has taken a hammering of more than 25 per cent.
